Looking beyond the hype: Applied AI and machine learning in translational medicine TS Toh, F Dondelinger, D Wang EBioMedicine 47, 607-615, 2019 | 126 | 2019 |
Defining subpopulations of differential drug response to reveal novel target populations N Keshava, TS Toh, H Yuan, B Yang, MP Menden, D Wang NPJ systems biology and applications 5 (1), 36, 2019 | 26 | 2019 |
A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates D Wang, J Hensman, G Kutkaite, TS Toh, A Galhoz, ... Elife 9, e60352, 2020 | 24 | 2020 |
A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis M Yan, S Sigurdson, N Greifer, TAC Kennedy, TS Toh, PE Lindsay, ... Cancers 13 (12), 2895, 2021 | 14 | 2021 |
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre M Yan, TS Toh, PE Lindsay, J Weiss, K Hueniken, C Yeung, V Sugumar, ... Clinical and translational radiation oncology 30, 43-49, 2021 | 7 | 2021 |
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities M Russo, M Chen, E Mariella, H Peng, SK Rehman, E Sancho, A Sogari, ... Nature Reviews Cancer, 1-24, 2024 | | 2024 |
Limited-Stage Small-Cell Lung Cancer: Current Progress and the Next Frontier TS Toh, BH Lok Radiation 1 (4), 317-333, 2021 | | 2021 |
131: Limited-Stage Small Cell Lung Cancer: Outcomes Associated with Prophylactic Cranial Irradiation Over A 20-Year Period At A Single Institution M Yan, TS Toh, P Lindsay, J Weiss, K Hueniken, V Sugumar, C Yeung, ... Radiotherapy and Oncology 150, S57, 2020 | | 2020 |
Outcomes of IMRT/VMAT vs 2D/3D-conformal thoracic radiation in limited stage small-cell lung cancer TS Toh, A Bang, D Pinto, K Hueniken, C Brown, W Xu, G Liu, B Lok Radiotherapy and Oncology 133, S399-S400, 2019 | | 2019 |